Cargando…

Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine

INTRODUCTION: Oxcarbazepine is a carbamazepine pre-drug with less drug interactions. Its adverse effects, including hyponatremia, somnolence and ataxia, are dose dependent. Olanzapine is an atypical antipsychotic drug most commonly used to manage psychoses and symptoms of irritability and aggressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalogera, Vasiliki, Galopoulos, Dimitrios, Eleftheriotis, Gerasimos, Meimeti, Evangelia, Malios, Ioannis, Marathonitis, Georgios, Loupa, Chariclia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences of Bosnia and Herzegovina 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195034/
https://www.ncbi.nlm.nih.gov/pubmed/30515002
http://dx.doi.org/10.5455/medarh.2018.72.303-305
_version_ 1783364336609132544
author Kalogera, Vasiliki
Galopoulos, Dimitrios
Eleftheriotis, Gerasimos
Meimeti, Evangelia
Malios, Ioannis
Marathonitis, Georgios
Loupa, Chariclia
author_facet Kalogera, Vasiliki
Galopoulos, Dimitrios
Eleftheriotis, Gerasimos
Meimeti, Evangelia
Malios, Ioannis
Marathonitis, Georgios
Loupa, Chariclia
author_sort Kalogera, Vasiliki
collection PubMed
description INTRODUCTION: Oxcarbazepine is a carbamazepine pre-drug with less drug interactions. Its adverse effects, including hyponatremia, somnolence and ataxia, are dose dependent. Olanzapine is an atypical antipsychotic drug most commonly used to manage psychoses and symptoms of irritability and aggressive behavior. Main side effects include extrapyramidal and anticholinergic symptoms, weight gain, and hyperglycemia. CASE REPORT: In this manuscript a case of oxcarbazepine and olanzapine intoxication is discussed. A 45-year-old woman, previously diagnosed with bipolar disorder and chronic alcoholism, was presented two hours after ingestion of 30,000mg of oxcarbazepine and 140 mg of olanzapine, combined with alcohol. She was immediately treated with gastric lavage and administration of activated charcoal. During her hospitalization she was hemodynamically and respiratory stable with no neurological signs and symptoms except for somnolence. Another side effect was hyponatremia. She was discharged from our department in stable clinical condition after being evaluated by a psychiatrist. CONCLUSION: Early approach is crucial for the management of drug intoxication. Late symptoms can be avoided through close monitoring of vital signs, mental status and laboratory values. Psychiatric consultation is essential for a better long-term outcome.
format Online
Article
Text
id pubmed-6195034
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Academy of Medical Sciences of Bosnia and Herzegovina
record_format MEDLINE/PubMed
spelling pubmed-61950342018-12-04 Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine Kalogera, Vasiliki Galopoulos, Dimitrios Eleftheriotis, Gerasimos Meimeti, Evangelia Malios, Ioannis Marathonitis, Georgios Loupa, Chariclia Med Arch Case Report INTRODUCTION: Oxcarbazepine is a carbamazepine pre-drug with less drug interactions. Its adverse effects, including hyponatremia, somnolence and ataxia, are dose dependent. Olanzapine is an atypical antipsychotic drug most commonly used to manage psychoses and symptoms of irritability and aggressive behavior. Main side effects include extrapyramidal and anticholinergic symptoms, weight gain, and hyperglycemia. CASE REPORT: In this manuscript a case of oxcarbazepine and olanzapine intoxication is discussed. A 45-year-old woman, previously diagnosed with bipolar disorder and chronic alcoholism, was presented two hours after ingestion of 30,000mg of oxcarbazepine and 140 mg of olanzapine, combined with alcohol. She was immediately treated with gastric lavage and administration of activated charcoal. During her hospitalization she was hemodynamically and respiratory stable with no neurological signs and symptoms except for somnolence. Another side effect was hyponatremia. She was discharged from our department in stable clinical condition after being evaluated by a psychiatrist. CONCLUSION: Early approach is crucial for the management of drug intoxication. Late symptoms can be avoided through close monitoring of vital signs, mental status and laboratory values. Psychiatric consultation is essential for a better long-term outcome. Academy of Medical Sciences of Bosnia and Herzegovina 2018-10 /pmc/articles/PMC6195034/ /pubmed/30515002 http://dx.doi.org/10.5455/medarh.2018.72.303-305 Text en © 2018 Vasiliki Kalogera, Dimitrios Galopoulos, Gerasimos Eleftheriotis, Evangelia Meimeti, Ioannis Malios, Georgios Marathonitis, Chariclia Loupa http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kalogera, Vasiliki
Galopoulos, Dimitrios
Eleftheriotis, Gerasimos
Meimeti, Evangelia
Malios, Ioannis
Marathonitis, Georgios
Loupa, Chariclia
Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine
title Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine
title_full Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine
title_fullStr Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine
title_full_unstemmed Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine
title_short Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine
title_sort patient survival after acute voluntary poisoning with a huge dose of oxcarbazepine and olanzapine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195034/
https://www.ncbi.nlm.nih.gov/pubmed/30515002
http://dx.doi.org/10.5455/medarh.2018.72.303-305
work_keys_str_mv AT kalogeravasiliki patientsurvivalafteracutevoluntarypoisoningwithahugedoseofoxcarbazepineandolanzapine
AT galopoulosdimitrios patientsurvivalafteracutevoluntarypoisoningwithahugedoseofoxcarbazepineandolanzapine
AT eleftheriotisgerasimos patientsurvivalafteracutevoluntarypoisoningwithahugedoseofoxcarbazepineandolanzapine
AT meimetievangelia patientsurvivalafteracutevoluntarypoisoningwithahugedoseofoxcarbazepineandolanzapine
AT maliosioannis patientsurvivalafteracutevoluntarypoisoningwithahugedoseofoxcarbazepineandolanzapine
AT marathonitisgeorgios patientsurvivalafteracutevoluntarypoisoningwithahugedoseofoxcarbazepineandolanzapine
AT loupachariclia patientsurvivalafteracutevoluntarypoisoningwithahugedoseofoxcarbazepineandolanzapine